{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:43:34Z","timestamp":1791895414882,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11035-8","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:52:31Z","timestamp":1759999951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A2M-AS1, DBH-AS1, and NCBP2-AS2 in breast cancer: expression patterns, CA125-3 association, and a DBH-AS1\u2013NCBP2-AS2 axis"],"prefix":"10.1007","volume":"52","author":[{"given":"Eman A. E.","family":"Badr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagar G.","family":"Alashkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala Said","family":"El-Rebey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A. E.","family":"Khlosy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Abdel-Rahim","family":"Ghobashy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammed Mohamed","family":"Abdelbary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"6","key":"11035_CR1","first-page":"477","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J, Siegel RL (2024) Breast cancer statistics 2024. CA Cancer J Clin 74(6):477\u2013495","journal-title":"CA Cancer J Clin"},{"key":"11035_CR2","doi-asserted-by":"crossref","unstructured":"Bessi K, Mbenza DLY (2022) Epidemiology of gynecological and mammary cancers in Africa: viral etiology and risk factors. Oncogenic Viruses Volume 1: Fundamentals of Oncoviruses, : p. 289","DOI":"10.1016\/B978-0-12-824152-3.00008-1"},{"key":"11035_CR3","doi-asserted-by":"crossref","unstructured":"Elhawary NA, Ekram SN, Sembawa HA, Tashkandi E, Bannani S, Azher ZA, Elhawary AN (2025) Descriptive epidemiology of female breast cancer around the world: incidence, mortality, and sociodemographic risks and disparities. Int J Environ Health Res, 1\u201315","DOI":"10.1080\/09603123.2025.2492826"},{"key":"11035_CR4","doi-asserted-by":"crossref","unstructured":"Alex A, Bhandary E, McGuire KP (2020) Anatomy and Physiology of the Breast during Pregnancy and Lactation. Diseases of the Breast during Pregnancy and Lactation, : pp. 3\u20137","DOI":"10.1007\/978-3-030-41596-9_1"},{"key":"11035_CR5","unstructured":"Screening P, Board PE (2024) Breast Cancer Screening (PDQ\u00ae), in PDQ Cancer Information Summaries [Internet]. National Cancer Institute (US)"},{"issue":"9291","key":"11035_CR6","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","volume":"358","author":"CG Cancer","year":"2001","unstructured":"Cancer CG (2001) o.H.F.i.B., Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 358(9291):1389\u20131399","journal-title":"Lancet"},{"key":"11035_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1096-0","volume":"38","author":"B Pang","year":"2019","unstructured":"Pang B et al (2019) Landscape of tumor suppressor long noncoding RNAs in breast cancer. J Exp Clin Cancer Res 38:1\u201318","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"11035_CR8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41419-019-1741-8","volume":"10","author":"B Ai","year":"2019","unstructured":"Ai B et al (2019) LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1. Cell Death Dis 10(7):502","journal-title":"Cell Death Dis"},{"key":"11035_CR9","unstructured":"NCBI. DBH-AS1 DBH antisense RNA 1 [ Homo sapiens (human) ] (2025) [cited 2025 11-Jun]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/138948"},{"key":"11035_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/09603271221138971","volume":"41","author":"H Guo","year":"2022","unstructured":"Guo H, Li T, Peng C, Mao Q, Shen B, Shi M, Liu Y (2022) Overexpression of LncRNA A2M-AS1 inhibits cell growth and aggressiveness via regulating the miR-587\/bone morphogenetic protein 3 axis in lung adenocarcinoma. Hum Exp Toxicol 41:09603271221138971","journal-title":"Hum Exp Toxicol"},{"key":"11035_CR11","first-page":"14","volume":"24","author":"XX Chen","year":"2020","unstructured":"Chen XX, Zhang N, Fu XF, Jiang Y, Wang MY (2020) LncRNA DBH-AS1 facilitates the tumorigenesis of melanoma by targeting miR-233-3p via IGF-1R\/Akt signaling. Eur Rev Med Pharmacol Sci 24:14","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"11035_CR12","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301019RR","volume":"37","author":"J Deng","year":"2023","unstructured":"Deng J, Xu W, Jie Y, Chong Y (2023) Subcellular localization and relevant mechanisms of human cancer-related micropeptides. FASEB J 37(12):e23270","journal-title":"FASEB J"},{"key":"11035_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.biopha.2018.08.079","volume":"107","author":"J Bao","year":"2018","unstructured":"Bao J et al (2018) LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK\/Src\/ERK pathway. Biomed Pharmacother 107:824\u2013833","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"11035_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/cbin.11327","volume":"44","author":"Y Song","year":"2020","unstructured":"Song Y et al (2020) Long non-coding RNA DBH\u2010AS1 promotes cancer progression in diffuse large B\u2010cell lymphoma by targeting FN1 via RNA\u2010binding protein BUD13. Cell Biol Int 44(6):1331\u20131340","journal-title":"Cell Biol Int"},{"key":"11035_CR15","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201902_17098","author":"Z-B Liu","year":"2019","unstructured":"Liu Z-B, Wang J-A, Lv R-Q (2019) Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Eur Rev Med Pharmacol Sci. https:\/\/doi.org\/10.26355\/eurrev_201902_17098","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11035_CR16","unstructured":"NCBI. A2M-AS1 A2M antisense RNA 1 [ Homo sapiens (human) ] (2025) [cited 2025 11-jun]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/144571"},{"key":"11035_CR17","unstructured":"NCBI. NCBP2AS2 NCBP2 antisense 2 (head to head) [ Homo sapiens (human) ] (2025) [cited 2025 11-Jun]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/152217"},{"issue":"6","key":"11035_CR18","first-page":"524","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN et al (2022) Breast cancer statistics, 2022. CA Cancer J Clin 72(6):524\u2013541","journal-title":"CA Cancer J Clin"},{"key":"11035_CR19","unstructured":"Organization WH (2024) Breast cancer. [cited 2025 3-jun]; Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer"},{"key":"11035_CR20","unstructured":"Chen X-X et al (2020) LncRNA DBH-AS1 facilitates the tumorigenesis of melanoma by targeting miR-233-3p via IGF-1R\/Akt signaling, vol 24. European Review for Medical & Pharmacological Sciences, 14"},{"issue":"6","key":"11035_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/10454411010120060301","volume":"12","author":"G Thomas","year":"2001","unstructured":"Thomas G, Speight P (2001) Cell adhesion molecules and oral cancer. Crit Rev Oral Biol Med 12(6):479\u2013498","journal-title":"Crit Rev Oral Biol Med"},{"issue":"2","key":"11035_CR22","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3892\/mmr.2015.4687","volume":"13","author":"Y Kimura","year":"2016","unstructured":"Kimura Y et al (2016) Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer. Mol Med Rep 13(2):1551\u20131557","journal-title":"Mol Med Rep"},{"key":"11035_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1023\/A:1020886801674","volume":"76","author":"J Quong","year":"2002","unstructured":"Quong J et al (2002) Age-dependent changes in breast cancer hormone receptors and oxidant stress markers. Breast Cancer Res Treat 76:221\u2013236","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"11035_CR24","first-page":"2900","volume":"45","author":"A Van Landeghem","year":"1985","unstructured":"Van Landeghem A et al (1985) Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45(6):2900\u20132906","journal-title":"Cancer Res"},{"issue":"23","key":"11035_CR25","doi-asserted-by":"publisher","first-page":"8550","DOI":"10.1158\/0008-5472.CAN-04-2151","volume":"64","author":"JB Geigl","year":"2004","unstructured":"Geigl JB et al (2004) Analysis of gene expression patterns and chromosomal changes associated with aging. Cancer Res 64(23):8550\u20138557","journal-title":"Cancer Res"},{"issue":"11","key":"11035_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ejso.2011.08.044","volume":"37","author":"F Badru","year":"2011","unstructured":"Badru F, Chianakwalam C, Stevenson V (2011) Laterality of breast cancer-is it true? Eur J Surg Oncol 37(11):987","journal-title":"Eur J Surg Oncol"},{"key":"11035_CR27","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S182254","author":"S-A Cheng","year":"2018","unstructured":"Cheng S-A et al (2018) Breast cancer laterality and molecular subtype likely share a common risk factor. Cancer Manag Res. https:\/\/doi.org\/10.2147\/CMAR.S182254","journal-title":"Cancer Manag Res"},{"issue":"9612","key":"11035_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569\u2013578","journal-title":"Lancet"},{"issue":"10","key":"11035_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/cac2.12075","volume":"40","author":"Y Xu","year":"2020","unstructured":"Xu Y et al (2020) The FTO\/miR-181b\u20103p\/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Cancer Commun 40(10):484\u2013500","journal-title":"Cancer Commun"},{"issue":"1","key":"11035_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05771-x","volume":"22","author":"G Zhang","year":"2024","unstructured":"Zhang G et al (2024) N6-methyladenosine methylation modification in breast cancer: current insights. J Transl Med 22(1):971","journal-title":"J Transl Med"},{"key":"11035_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10549-018-4796-9","volume":"170","author":"V Sopik","year":"2018","unstructured":"Sopik V, Narod SA (2018) The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Res Treat 170:647\u2013656","journal-title":"Breast Cancer Res Treat"},{"key":"11035_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10549-010-1135-1","volume":"124","author":"Z Gabos","year":"2010","unstructured":"Gabos Z et al (2010) The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Res Treat 124:187\u2013194","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"11035_CR33","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.21608\/ejhm.2019.43806","volume":"76","author":"ER El Gammal","year":"2019","unstructured":"El Gammal ER, Abdulmohaymen AM, Abdulmutaleb BAM (2019) Comparative study between Conservative breast surgery and modified radical mastectomy in triple negative cases. Egypt J Hosp Med 76(6):4269\u20134273","journal-title":"Egypt J Hosp Med"},{"issue":"15","key":"11035_CR34","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1001\/jama.1997.03550150100051","volume":"278","author":"WM Recant","year":"1997","unstructured":"Recant WM (1997) Rosen\u2019s breast pathology. JAMA 278(15):1292\u20131293","journal-title":"JAMA"},{"key":"11035_CR35","doi-asserted-by":"crossref","unstructured":"Turashvili G et al (2007) Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas, vol 151. Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 1","DOI":"10.5507\/bp.2007.010"},{"key":"11035_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10549-021-06148-0","volume":"188","author":"F Fei","year":"2021","unstructured":"Fei F, Siegal GP, Wei S (2021) Characterization of estrogen receptor-low-positive breast cancer. Breast Cancer Res Treat 188:225\u2013235","journal-title":"Breast Cancer Res Treat"},{"issue":"17","key":"11035_CR37","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/jnci\/dji249","volume":"97","author":"G Arpino","year":"2005","unstructured":"Arpino G et al (2005) Estrogen receptor\u2013positive, progesterone receptor\u2013negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst 97(17):1254\u20131261","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"11035_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.rbmo.2022.09.014","volume":"46","author":"S Yildiz","year":"2023","unstructured":"Yildiz S et al (2023) Breast cancer treatment and ovarian function. Reprod Biomed Online 46(2):313\u2013331","journal-title":"Reprod Biomed Online"},{"issue":"38","key":"11035_CR39","doi-asserted-by":"publisher","first-page":"63963","DOI":"10.18632\/oncotarget.19246","volume":"8","author":"C Fang","year":"2017","unstructured":"Fang C et al (2017) Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes. Oncotarget 8(38):63963","journal-title":"Oncotarget"},{"issue":"6","key":"11035_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/13547500701520563","volume":"12","author":"D Baski\u0107","year":"2007","unstructured":"Baski\u0107 D et al (2007) Clinical evaluation of the simultaneous determination of CA 15\u2009\u2013\u20093, CA 125 and sHER2 in breast cancer. Biomarkers 12(6):657\u2013667","journal-title":"Biomarkers"},{"key":"11035_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10549-016-3950-5","volume":"159","author":"CM Focke","year":"2016","unstructured":"Focke CM, van Diest PJ, Decker T (2016) St gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods. Breast Cancer Res Treat 159:257\u2013263","journal-title":"Breast Cancer Res Treat"},{"key":"11035_CR42","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S278564","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020) Long non-coding RNA A2M-AS1 promotes breast cancer progression by sponging microrna-146b to upregulate MUC19. Int J Gen Med. https:\/\/doi.org\/10.2147\/IJGM.S278564","journal-title":"Int J Gen Med"},{"issue":"6","key":"11035_CR43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.21037\/atm-22-556","volume":"10","author":"X Ye","year":"2022","unstructured":"Ye X et al (2022) Increased m6A modification of LncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163\/USP44 axis. Ann Transl Med 10(6):304","journal-title":"Ann Transl Med"},{"issue":"32","key":"11035_CR44","doi-asserted-by":"publisher","first-page":"33791","DOI":"10.18632\/oncotarget.5667","volume":"6","author":"J-l Huang","year":"2015","unstructured":"Huang J-l et al (2015) HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma. Oncotarget 6(32):33791","journal-title":"Oncotarget"},{"key":"11035_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2025.109428","volume":"198","author":"T Li","year":"2025","unstructured":"Li T et al (2025) Triphenyl phosphate induces lipid metabolism disorder and promotes obesity through PI3K\/AKT signaling pathway. Environ Int 198:109428","journal-title":"Environ Int"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11035-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11035-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11035-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:03:23Z","timestamp":1766898203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11035-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11035"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11035-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study design has been approved by the appropriate ethics review board, followed the tenets of the Declaration of Helsinki and also by the ethics committee of the Faculty of Medicine, Menoufia University. IRB: 4\/2024BIO7-2.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study. The authors affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"996"}}